- Report
- August 2024
- 113 Pages
United States
From €4505EUR$4,950USD£3,862GBP
- Report
- March 2024
- 351 Pages
Global
From €5252EUR$5,972USD£4,350GBP
- Report
- January 2024
- 143 Pages
Global
From €3868EUR$4,250USD£3,316GBP
- Report
- February 2024
- 120 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- February 2024
- 112 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Report
- April 2023
- 111 Pages
Global
From €4323EUR$4,750USD£3,706GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €455EUR$500USD£390GBP
Nexplanon is a long-acting, reversible contraceptive (LARC) device used to prevent pregnancy. It is a small, thin, and flexible rod that is inserted under the skin of the upper arm and releases a low dose of progestin over a three-year period. It is a popular form of contraception among women due to its convenience and effectiveness. It is also a safe and reliable form of contraception, with few side effects.
Nexplanon is available in many countries around the world, and is marketed by a number of pharmaceutical companies. It is often prescribed by healthcare providers as an alternative to other forms of contraception, such as the birth control pill. It is also used by women who are unable to take the pill due to medical conditions or lifestyle choices.
The Nexplanon market is an important part of the Women's Health industry, providing a safe and reliable form of contraception for women. Companies in the market include Merck, Bayer, and Teva Pharmaceuticals. Show Less Read more